Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.

Paolino K, Sande J, Perez E, Loechelt B, Jantausch B, Painter W, Anderson M, Tippin T, Lanier ER, Fry T, DeBiasi RL.

J Clin Virol. 2011 Feb;50(2):167-70. doi: 10.1016/j.jcv.2010.10.016. Epub 2010 Nov 19.

PMID:
21094081
2.

Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.

Muller WJ, Levin MJ, Shin YK, Robinson C, Quinones R, Malcolm J, Hild E, Gao D, Giller R.

Clin Infect Dis. 2005 Dec 15;41(12):1812-6. Epub 2005 Nov 7.

PMID:
16288409
3.

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children.

Gavin PJ, Katz BZ.

Pediatrics. 2002 Jul;110(1 Pt 1):e9. Review.

PMID:
12093990
4.

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.

Yusuf U, Hale GA, Carr J, Gu Z, Benaim E, Woodard P, Kasow KA, Horwitz EM, Leung W, Srivastava DK, Handgretinger R, Hayden RT.

Transplantation. 2006 May 27;81(10):1398-404.

PMID:
16732176
5.

Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.

Ribaud P, Scieux C, Freymuth F, Morinet F, Gluckman E.

Clin Infect Dis. 1999 Mar;28(3):690-1. No abstract available.

PMID:
10194105
6.

[Disseminated and fatal adenovirus infection in an immunocompromised child].

Abarca V K, Le Corre P N, Perret P C, Wietstruck P A, Oddó B D, Barriga C F.

Rev Chilena Infectol. 2008 Apr;25(2):127-32. doi: /S0716-10182008000300008. Epub 2008 Apr 30. Spanish.

7.

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.

Florescu DF, Pergam SA, Neely MN, Qiu F, Johnston C, Way S, Sande J, Lewinsohn DA, Guzman-Cottrill JA, Graham ML, Papanicolaou G, Kurtzberg J, Rigdon J, Painter W, Mommeja-Marin H, Lanier R, Anderson M, van der Horst C.

Biol Blood Marrow Transplant. 2012 May;18(5):731-8. doi: 10.1016/j.bbmt.2011.09.007. Epub 2011 Sep 29.

8.

Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.

Sivaprakasam P, Carr TF, Coussons M, Khalid T, Bailey AS, Guiver M, Mutton KJ, Turner AJ, Grainger JD, Wynn RF.

J Pediatr Hematol Oncol. 2007 Feb;29(2):81-5.

PMID:
17279003
9.

Successful outcome of a disseminated adenovirus infection 6 years after allogeneic bone marrow transplantation.

Willems L, Lagrange-Xélot M, Gallien S, Robin M, Scieux C, Socié G, Molina JM.

Bone Marrow Transplant. 2008 Feb;41(4):411-2. Epub 2007 Nov 19. No abstract available.

PMID:
18026146
10.

Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.

Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P.

Biol Blood Marrow Transplant. 2007 Jan;13(1):74-81. Review.

11.

Successful response to cidofovir of adenovirus hepatitis during chemotherapy in a child with hepatoblastoma.

Mateos ME, López-Laso E, Pérez-Navero JL, Peña MJ, Velasco MJ.

J Pediatr Hematol Oncol. 2012 Oct;34(7):e298-300.

PMID:
22935664
12.

Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.

Symeonidis N, Jakubowski A, Pierre-Louis S, Jaffe D, Pamer E, Sepkowitz K, O'Reilly RJ, Papanicolaou GA.

Transpl Infect Dis. 2007 Jun;9(2):108-13.

PMID:
17461995
13.

The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.

Lugthart G, Oomen MA, Jol-van der Zijde CM, Ball LM, Bresters D, Kollen WJ, Smiers FJ, Vermont CL, Bredius RG, Schilham MW, van Tol MJ, Lankester AC.

Biol Blood Marrow Transplant. 2015 Feb;21(2):293-9. doi: 10.1016/j.bbmt.2014.10.012. Epub 2014 Oct 16.

14.

Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.

Caruso Brown AE, Cohen MN, Tong S, Braverman RS, Rooney JF, Giller R, Levin MJ.

Antimicrob Agents Chemother. 2015 Jul;59(7):3718-25. doi: 10.1128/AAC.04348-14. Epub 2015 Mar 2.

15.

Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.

Carter BA, Karpen SJ, Quiros-Tejeira RE, Chang IF, Clark BS, Demmler GJ, Heslop HE, Scott JD, Seu P, Goss JA.

Transplantation. 2002 Oct 15;74(7):1050-2.

PMID:
12394854
16.

Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.

Doan ML, Mallory GB, Kaplan SL, Dishop MK, Schecter MG, McKenzie ED, Heinle JS, Elidemir O.

J Heart Lung Transplant. 2007 Sep;26(9):883-9.

PMID:
17845926
17.

Diagnosis and treatment of adenovirus infection in immunocompromised patients.

Matthes-Martin S, Boztug H, Lion T.

Expert Rev Anti Infect Ther. 2013 Oct;11(10):1017-28. doi: 10.1586/14787210.2013.836964. Epub 2013 Sep 27. Review.

PMID:
24073835
18.

Antiviral therapy for adenovirus infections.

Lenaerts L, Naesens L.

Antiviral Res. 2006 Sep;71(2-3):172-80. Epub 2006 May 2. Review.

PMID:
16698093
19.

Safety and tolerability of cidofovir in high-risk pediatric patients.

Bhadri VA, Lee-Horn L, Shaw PJ.

Transpl Infect Dis. 2009 Aug;11(4):373-9. doi: 10.1111/j.1399-3062.2009.00391.x. Epub 2009 Apr 15.

PMID:
19392729
20.

Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir.

Nicolasora NP, Reddy P, Kaul DR.

Transpl Infect Dis. 2008 Oct;10(5):346-50. doi: 10.1111/j.1399-3062.2008.00303.x. Epub 2008 Feb 14.

Supplemental Content

Support Center